205 related articles for article (PubMed ID: 26578390)
21. Bioinformatics method to predict two regulation mechanism: TF-miRNA-mRNA and lncRNA-miRNA-mRNA in pancreatic cancer.
Ye S; Yang L; Zhao X; Song W; Wang W; Zheng S
Cell Biochem Biophys; 2014 Dec; 70(3):1849-58. PubMed ID: 25087086
[TBL] [Abstract][Full Text] [Related]
22. Identification of hub genes with diagnostic values in pancreatic cancer by bioinformatics analyses and supervised learning methods.
Li C; Zeng X; Yu H; Gu Y; Zhang W
World J Surg Oncol; 2018 Nov; 16(1):223. PubMed ID: 30428899
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA in pancreatic adenocarcinoma: predictive/prognostic biomarkers or therapeutic targets?
Brunetti O; Russo A; Scarpa A; Santini D; Reni M; Bittoni A; Azzariti A; Aprile G; Delcuratolo S; Signorile M; Gnoni A; Palermo L; Lorusso V; Cascinu S; Silvestris N
Oncotarget; 2015 Sep; 6(27):23323-41. PubMed ID: 26259238
[TBL] [Abstract][Full Text] [Related]
24. Characterization of gene expression and activated signaling pathways in solid-pseudopapillary neoplasm of pancreas.
Park M; Kim M; Hwang D; Park M; Kim WK; Kim SK; Shin J; Park ES; Kang CM; Paik YK; Kim H
Mod Pathol; 2014 Apr; 27(4):580-93. PubMed ID: 24072181
[TBL] [Abstract][Full Text] [Related]
25. Noncoding RNAs as potential biomarkers to predict the outcome in pancreatic cancer.
Jin K; Luo G; Xiao Z; Liu Z; Liu C; Ji S; Xu J; Liu L; Long J; Ni Q; Yu X
Drug Des Devel Ther; 2015; 9():1247-55. PubMed ID: 25750521
[TBL] [Abstract][Full Text] [Related]
26. Sex differences in immunohistochemical expression and capillary density in pancreatic solid pseudopapillary neoplasm.
Hirabayashi K; Kurokawa S; Maruno A; Yamada M; Kawaguchi Y; Nakagohri T; Mine T; Sugiyama T; Tajiri T; Nakamura N
Ann Diagn Pathol; 2015 Apr; 19(2):45-9. PubMed ID: 25744912
[TBL] [Abstract][Full Text] [Related]
27. Identification of molecular biomarkers for pancreatic cancer with mRMR shortest path method.
Shen S; Gui T; Ma C
Oncotarget; 2017 Jun; 8(25):41432-41439. PubMed ID: 28611293
[TBL] [Abstract][Full Text] [Related]
28. Circulating microRNAs in serum of human K-ras oncogene transgenic rats with pancreatic ductal adenocarcinomas.
Yabushita S; Fukamachi K; Tanaka H; Sumida K; Deguchi Y; Sukata T; Kawamura S; Uwagawa S; Suzui M; Tsuda H
Pancreas; 2012 Oct; 41(7):1013-8. PubMed ID: 22513294
[TBL] [Abstract][Full Text] [Related]
29. E-cadherin/beta-catenin and CD10: a limited immunohistochemical panel to distinguish pancreatic endocrine neoplasm from solid pseudopapillary neoplasm of the pancreas on endoscopic ultrasound-guided fine-needle aspirates of the pancreas.
Burford H; Baloch Z; Liu X; Jhala D; Siegal GP; Jhala N
Am J Clin Pathol; 2009 Dec; 132(6):831-9. PubMed ID: 19926573
[TBL] [Abstract][Full Text] [Related]
30. miRNA-21 and miRNA-34a Are Potential Minimally Invasive Biomarkers for the Diagnosis of Pancreatic Ductal Adenocarcinoma.
Alemar B; Izetti P; Gregório C; Macedo GS; Castro MA; Osvaldt AB; Matte U; Ashton-Prolla P
Pancreas; 2016 Jan; 45(1):84-92. PubMed ID: 26262588
[TBL] [Abstract][Full Text] [Related]
31. Solid pseudopapillary neoplasm (SPN) of the pancreas: current understanding on its malignant potential and management.
Lu X; Chen H; Zhang T
Discov Oncol; 2024 Mar; 15(1):77. PubMed ID: 38498246
[TBL] [Abstract][Full Text] [Related]
32. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
33. Molecular profiling of pancreatic neuroendocrine tumors in sporadic and Von Hippel-Lindau patients.
Speisky D; Duces A; Bièche I; Rebours V; Hammel P; Sauvanet A; Richard S; Bedossa P; Vidaud M; Murat A; Niccoli P; Scoazec JY; Ruszniewski P; Couvelard A;
Clin Cancer Res; 2012 May; 18(10):2838-49. PubMed ID: 22461457
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis and molecular aspects of solid-pseudopapillary neoplasms of the pancreas.
Terris B; Cavard C
Semin Diagn Pathol; 2014 Nov; 31(6):484-490. PubMed ID: 25524568
[TBL] [Abstract][Full Text] [Related]
35. MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma.
Vychytilova-Faltejskova P; Kiss I; Klusova S; Hlavsa J; Prochazka V; Kala Z; Mazanec J; Hausnerova J; Kren L; Hermanova M; Lenz J; Karasek P; Vyzula R; Slaby O
Diagn Pathol; 2015 Apr; 10():38. PubMed ID: 25908274
[TBL] [Abstract][Full Text] [Related]
36. Key endoscopic ultrasound features of pancreatic ductal adenocarcinoma smaller than 20 mm.
Aso A; Ihara E; Osoegawa T; Nakamura K; Itaba S; Igarashi H; Ito T; Aishima S; Oda Y; Tanaka M; Takayanagi R
Scand J Gastroenterol; 2014 Mar; 49(3):332-8. PubMed ID: 24417737
[TBL] [Abstract][Full Text] [Related]
37. The dilemma of "indeterminate" interpretations of pancreatic neuroendocrine tumors on fine needle aspiration.
Ahmed A; VandenBussche CJ; Ali SZ; Olson MT
Diagn Cytopathol; 2016 Jan; 44(1):10-3. PubMed ID: 26402138
[TBL] [Abstract][Full Text] [Related]
38. [Solid pseudopapillary epithelial pancreatic tumor].
Kuryk OH; Kucher MD; Iakovenko VO; Kriuchyna IeA
Klin Khir; 2009 May; (5):9-13. PubMed ID: 19957740
[TBL] [Abstract][Full Text] [Related]
39. Distinction of Invasive Carcinoma Derived From Intraductal Papillary Mucinous Neoplasms From Concomitant Ductal Adenocarcinoma of the Pancreas Using Molecular Biomarkers.
Tamura K; Ohtsuka T; Date K; Fujimoto T; Matsunaga T; Kimura H; Watanabe Y; Miyazaki T; Ohuchida K; Takahata S; Ishigami K; Oda Y; Mizumoto K; Nakamura M; Tanaka M
Pancreas; 2016 Jul; 45(6):826-35. PubMed ID: 26646266
[TBL] [Abstract][Full Text] [Related]
40. Comparative study of non-functional islet cell tumors and pancreatic solid and papillary neoplasms: biological behavior and immunohistochemistry.
Choi YL; Oh YL; Kim SH; Park CK; Ahn G
Pathol Int; 2002; 52(5-6):358-66. PubMed ID: 12100518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
